2j1x
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | {{Seed}} | ||
[[Image:2j1x.png|left|200px]] | [[Image:2j1x.png|left|200px]] | ||
Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
- | + | [[2j1x]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2J1X OCA]. | |
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID:17015838</ref><references group="xtra"/> | + | <ref group="xtra">PMID:17015838</ref><ref group="xtra">PMID:14534297</ref><ref group="xtra">PMID:15703170</ref><references group="xtra"/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Fersht, A R.]] | [[Category: Fersht, A R.]] | ||
Line 38: | Line 37: | ||
[[Category: Glycoprotein]] | [[Category: Glycoprotein]] | ||
[[Category: Host-virus interaction]] | [[Category: Host-virus interaction]] | ||
+ | [[Category: Li- fraumeni syndrome]] | ||
[[Category: Li-fraumeni syndrome]] | [[Category: Li-fraumeni syndrome]] | ||
[[Category: Metal-binding]] | [[Category: Metal-binding]] | ||
Line 51: | Line 51: | ||
[[Category: Tumor suppressor]] | [[Category: Tumor suppressor]] | ||
[[Category: Zinc]] | [[Category: Zinc]] | ||
- | |||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 16:58:19 2009'' |
Revision as of 00:32, 15 March 2011
HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y220C-N239Y-N268D
Template:ABSTRACT PUBMED 17015838
About this Structure
2j1x is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Joerger AC, Ang HC, Fersht AR. Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15056-61. Epub 2006 Oct 2. PMID:17015838
- Joerger AC, Allen MD, Fersht AR. Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations. J Biol Chem. 2004 Jan 9;279(2):1291-6. Epub 2003 Oct 8. PMID:14534297 doi:10.1074/jbc.M309732200
- Joerger AC, Ang HC, Veprintsev DB, Blair CM, Fersht AR. Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations. J Biol Chem. 2005 Apr 22;280(16):16030-7. Epub 2005 Feb 9. PMID:15703170 doi:http://dx.doi.org/10.1074/jbc.M500179200
Categories: Homo sapiens | Fersht, A R. | Joerger, A C. | Acetylation | Activator | Alternative splicing | Anti-oncogene | Apoptosis | Cell cycle | Disease mutation | Dna-binding | Dna-binding protein | Glycoprotein | Host-virus interaction | Li- fraumeni syndrome | Li-fraumeni syndrome | Metal-binding | Nuclear protein | P53 dna-binding domain | Phosphorylation | Polymorphism | Second-site suppressor mutation | Superstable mutant | Transcription | Transcription regulation | Transferase | Tumor suppressor | Zinc